RhumbLine Advisers’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-327,189
| Closed | -$13.8M | – | 4388 |
|
|
2023
Q2 | $13.8M | Buy |
327,189
+7,335
| +2% | +$297K | 0.02% | 847 |
|
|
2023
Q1 | $11.4M | Buy |
319,854
+2,852
| +0.9% | +$103K | 0.01% | 903 |
|
|
2022
Q4 | $11.6M | Buy |
317,002
+23,716
| +8% | +$937K | 0.02% | 859 |
|
|
2022
Q3 | $13.8M | Buy |
293,286
+7,141
| +2% | +$461K | 0.02% | 719 |
|
|
2022
Q2 | $20.5M | Buy |
286,145
+24,920
| +10% | +$1.82M | 0.03% | 519 |
|
|
2022
Q1 | $21.1M | Sell |
261,225
-4,948
| -2% | -$419K | 0.03% | 552 |
|
|
2021
Q4 | $27.3M | Buy |
266,173
+5,403
| +2% | +$519K | 0.03% | 473 |
|
|
2021
Q3 | $22.8M | Sell |
260,770
-1,229
| -0.5% | -$111K | 0.03% | 513 |
|
|
2021
Q2 | $23.4M | Buy |
261,999
+46,124
| +21% | +$3.9M | 0.03% | 528 |
|
|
2021
Q1 | $16.4M | Buy |
215,875
+17,856
| +9% | +$1.35M | 0.02% | 699 |
|
|
2020
Q4 | $13.5M | Buy |
198,019
+18,577
| +10% | +$1.16M | 0.02% | 754 |
|
|
2020
Q3 | $9.54M | Buy |
179,442
+6,405
| +4% | +$381K | 0.01% | 804 |
|
|
2020
Q2 | $10.1M | Sell |
173,037
-43,053
| -20% | -$2.31M | 0.02% | 767 |
|
|
2020
Q1 | $8.52M | Buy |
216,090
+6,602
| +3% | +$386K | 0.02% | 732 |
|
|
2019
Q4 | $12.5M | Buy |
209,488
+5,084
| +2% | +$273K | 0.02% | 713 |
|
|
2019
Q3 | $10.9M | Buy |
204,404
+7,083
| +4% | +$363K | 0.02% | 727 |
|
|
2019
Q2 | $10.1M | Buy |
197,321
+2,730
| +1% | +$127K | 0.02% | 769 |
|
|
2019
Q1 | $10.1M | Buy |
194,591
+3,170
| +2% | +$154K | 0.02% | 752 |
|
|
2018
Q4 | $7.53M | Buy |
191,421
+77,875
| +69% | +$3.62M | 0.02% | 862 |
|
|
2018
Q3 | $5.85M | Buy |
113,546
+10,753
| +10% | +$527K | 0.01% | 1011 |
|
|
2018
Q2 | $4.82M | Buy |
102,793
+5,950
| +6% | +$246K | 0.01% | 1122 |
|
|
2018
Q1 | $3.44M | Sell |
96,843
-4,385
| -4% | -$172K | 0.01% | 1284 |
|
|
2017
Q4 | $4.41M | Sell |
101,228
-26,292
| -21% | -$1.23M | 0.01% | 1145 |
|
|
2017
Q3 | $6.67M | Buy |
127,520
+21,216
| +20% | +$1.18M | 0.01% | 861 |
|
|
2017
Q2 | $6.22M | Buy |
106,304
+57,983
| +120% | +$3.01M | 0.01% | 879 |
|
|
2017
Q1 | $2.22M | Buy |
48,321
+2,949
| +6% | +$147K | 0.01% | 1487 |
|
|
2016
Q4 | $2.39M | Buy |
45,372
+1,999
| +5% | +$96.8K | 0.01% | 1343 |
|
|
2016
Q3 | $1.93M | Buy |
43,373
+7,200
| +20% | +$312K | 0.01% | 1421 |
|
|
2016
Q2 | $1.38M | Buy |
36,173
+22,729
| +169% | +$999K | ﹤0.01% | 1594 |
|
|
2016
Q1 | $554K | Buy |
13,444
+680
| +5% | +$28K | ﹤0.01% | 2157 |
|
|
2015
Q4 | $619K | Buy |
12,764
+820
| +7% | +$36.5K | ﹤0.01% | 2112 |
|
|
2015
Q3 | $478K | Buy |
11,944
+514
| +4% | +$22.4K | ﹤0.01% | 2253 |
|
|
2015
Q2 | $459K | Buy |
11,430
+4,930
| +76% | +$170K | ﹤0.01% | 2389 |
|
|
2015
Q1 | $213K | Buy |
+6,500
| New | +$180K | ﹤0.01% | 2806 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
RhumbLine Advisers's SYNH Position: Q3 2023 in Review
RhumbLine Advisers sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 327,189 shares — an estimated $13.8M sold.
RhumbLine Advisers first reported a position in SYNH in Q1 2015 and held it in 34 quarters. The position peaked at $27.3M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- RhumbLine Advisers reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- RhumbLine Advisers sold 327,189 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $13.8M.
- RhumbLine Advisers first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 34 quarters.
- RhumbLine Advisers's Syneos Health, Inc. Class A Common Stock position peaked at $27.3M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.